|
1
|
Ikushima H and Miyazono K: TGFbeta
signalling: A complex web in cancer progression. Nat Rev Cancer.
10:415–424. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mo JS, Park HW and Guan KL: The Hippo
signaling pathway in stem cell biology and cancer. EMBO Rep.
15:642–656. 2014.PubMed/NCBI
|
|
3
|
Johnson R and Halder G: The two faces of
Hippo: Targeting the Hippo pathway for regenerative medicine and
cancer treatment. Nat Rev Drug Discov. 13:63–79. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Piccolo S, Dupont S and Cordenonsi M: The
biology of YAP/TAZ: Hippo signaling and beyond. Physiol Rev.
94:1287–1312. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Harvey KF, Zhang X and Thomas DM: The
Hippo pathway and human cancer. Nat Rev Cancer. 13:246–257. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Santucci M, Vignudelli T, Ferrari S, Mor
M, Scalvini L, Bolognesi ML, Uliassi E and Costi MP: The Hippo
pathway and YAP/TAZ-TEAD protein-protein interaction as targets for
regenerative medicine and cancer treatment. J Med Chem.
58:4857–4873. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Justice N, Roegiers F, Jan LY and Jan YN:
Lethal giant larvae acts together with numb in notch inhibition and
cell fate specification in the Drosophila adult sensory organ
precursor lineage. Curr Biol. 13:778–783. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Xu T, Wang W, Zhang S, Stewart RA and Yu
W: Identifying tumor suppressors in genetic mosaics: The Drosophila
lats gene encodes a putative protein kinase. Development.
121:1053–1063. 1995.PubMed/NCBI
|
|
9
|
Tapon N, Harvey KF, Bell DW, Wahrer DC,
Schiripo TA, Haber D and Hariharan IK: salvador Promotes both cell
cycle exit and apoptosis in Drosophila and is mutated in human
cancer cell lines. Cell. 110:467–478. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cui ZL, Han FF, Peng XH, Chen X, Luan CY,
Han RC, Xu WG and Guo XJ: YES-associated protein 1 promotes
adenocarcinoma growth and metastasis through activation of the
receptor tyrosine kinase Axl. Int J Immunopathol Pharmacol.
25:989–1001. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Pei T, Li Y, Wang J, Wang H, Liang Y, Shi
H, Sun B, Yin D, Sun J, Song R, et al: YAP is a critical oncogene
in human cholangiocarcinoma. Oncotarget. 6:17206–17220. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhao B, Wei X, Li W, Udan RS, Yang Q, Kim
J, Xie J, Ikenoue T, Yu J, Li L, et al: Inactivation of YAP
oncoprotein by the Hippo pathway is involved in cell contact
inhibition and tissue growth control. Genes Dev. 21:2747–2761.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Dong J, Feldmann G, Huang J, Wu S, Zhang
N, Comerford SA, Gayyed MF, Anders RA, Maitra A and Pan D:
Elucidation of a universal size-control mechanism in Drosophila and
mammals. Cell. 130:1120–1133. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Steinhardt AA, Gayyed MF, Klein AP, Dong
J, Maitra A, Pan D, Montgomery EA and Anders RA: Expression of
Yes-associated protein in common solid tumors. Hum Pathol.
39:1582–1589. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang X, George J, Deb S, Degoutin JL,
Takano EA, Fox SB; AOCS Study group, ; Bowtell DD and Harvey KF:
The Hippo pathway transcriptional co-activator, YAP, is an ovarian
cancer oncogene. Oncogene. 30:2810–2822. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hall CA, Wang R, Miao J, Oliva E, Shen X,
Wheeler T, Hilsenbeck SG, Orsulic S and Goode S: Hippo pathway
effector Yap is an ovarian cancer oncogene. Cancer Res.
70:8517–8525. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nallet-Staub F, Marsaud V, Li L, Gilbert
C, Dodier S, Betaille V, Sudol M, Herlyn M and Mauviel A:
Pro-invasive activity of the Hippo pathway effectors YAP and TAZ in
cutaneous melanoma. J Invest Dermatol. 134:123–132. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bhat KP, Salazar KL, Balasubramaniyan V,
Wani K, Heathcock L, Hollingsworth F, James JD, Gumin J, Diefes KL,
Kim SH, et al: The transcriptional coactivator TAZ regulates
mesenchymal differentiation in malignant glioma. Genes Dev.
25:2594–2609. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cottini F, Hideshima T, Xu C, Sattler M,
Dori M, Agnelli L, ten Hacken E, Bertilaccio MT, Antonini E, Neri
A, et al: Rescue of Hippo coactivator YAP1 triggers DNA
damage-induced apoptosis in hematological cancers. Nat Med.
20:599–606. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang Y, Xie C, Li Q, Xu K and Wang E:
Clinical and prognostic significance of Yes-associated protein in
colorectal cancer. Tumour Biol. 34:2169–2174. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang L, Shi S, Guo Z, Zhang X, Han S, Yang
A, Wen W and Zhu A: Overexpression of YAP and TAZ is an independent
predictor of prognosis in colorectal cancer and related to the
proliferation and metastasis of colon cancer cells. PLoS One.
8:e655392013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liang K, Zhou G, Zhang Q, Li J and Zhang
C: Expression of hippo pathway in colorectal cancer. Saudi J
Gastroenterol. 20:188–194. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yuen HF, McCrudden CM, Huang YH, Tham JM,
Zhang X, Zeng Q, Zhang SD and Hong W: TAZ expression as a
prognostic indicator in colorectal cancer. PLoS One. 8:e542112013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
R Core Team, . R: A Language and
Environment for Statistical Computing. R Foundation for Statistical
Computing; Vienna, Austria: 2016
|
|
25
|
Golub TR, Slonim DK, Tamayo P, Huard C,
Baasenbeek M, Mersirov JP, Coller H, Loh ML, Downing JR, Caligiuri
MA, et al: Molecular classification of cancer: Class discovery and
class prediction by gene expression monitoring. Science.
286:531–537. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Huang DW, Sherman BT, Tan Q, Collins JR,
Alvord WG, Roayaei J, Stephens R, Baseler MW, Lane HC and Lempicki
RA: The DAVID gene functional classification tool: A novel
biological module-centric algorithm to functionally analyze large
gene lists. Genome Biol. 8:R1832007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kanehisa M, Goto S, Sato Y, Furumichi M
and Tanabe M: KEGG for integration and interpretation of
large-scale molecular data sets. Nucleic Acids Res. 40:D109–D114.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kanehisa M and Goto S: KEGG: Kyoto
Encyclopedia of Genes and Genomes. Nucleic Acids Res. 28:27–30.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Budczies J, Klauschen F, Sinn BV, Győrffy
B, Schmitt WD, Darb-Esfahani S and Denkert C: Cutoff Finder: A
comprehensive and straightforward Web application enabling rapid
biomarker cutoff optimization. PLoS One. 7:e518622012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hari DM, Leung AM, Lee JH, Sim MS, Vuong
B, Chiu CG and Bilchik AJ: AJCC cancer staging manual 7th edition
criteria for colon cancer: Do the complex modifications improve
prognostic assessment? J Am Coll Surg. 217:181–190. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Benedix F, Kube R, Meyer F, Schmidt U,
Gastinger I and Lippert H; Colon/Rectum Carcinomas (Primary Tumor)
Study Group, : Comparison of 17,641 patients with right- and
left-sided colon cancer: Differences in epidemiology, perioperative
course, histology and survival. Dis Colon Rectum. 53:57–64. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Papagiorgis P, Oikonomakis I,
Karapanagiotou I, Wexner SD and Nikiteas N: The impact of tumor
location on the histopathologic expression of colorectal cancer. J
Buon. 11:317–321. 2006.PubMed/NCBI
|
|
33
|
Glebov OK, Rodriguez LM, Nakahara K,
Jenkins J, Cliatt J, Humbyrd CJ, DeNobile J, Soballe P, Simon R,
Wright G, et al: Distinguishing right from left colon by the
pattern of gene expression. Cancer Epidemiol Biomarkers Prev.
12:755–762. 2003.PubMed/NCBI
|
|
34
|
Azzoni C, Bottarelli L, Campanini N, Di
Cola G, Bader G, Mazzeo A, Salvemini C, Morari S, Di Mauro D,
Donadei E, et al: Distinct molecular patterns based on proximal and
distal sporadic colorectal cancer: Arguments for different
mechanisms in the tumorigenesis. Int J Colorectal Dis. 22:115–126.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zender L, Spector MS, Xue W, Flemming P,
Cordon-Cardo C, Silke J, Fan ST, Luk JM, Wigler M, Hannon GJ, et
al: Identification and validation of oncogenes in liver cancer
using an integrative oncogenomic approach. Cell. 125:1253–1267.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Xu MZ, Yao TJ, Lee NP, Ng IO, Chan YT,
Znder L, Lowe SW, Poon RT and Luk JM: Yes-associated protein is an
independent prognostic marker in hepatocellular carcinoma. Cancer.
115:4576–4585. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Irvine KD: Integration of intercellular
signaling through the Hippo pathway. Semin Cell Dev Biol.
23:812–817. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhao B, Li L and Guan KL: Hippo signaling
at a glance. J Cell Sci. 123:4001–4006. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
DiMeo TA, Anderson K, Phadke P, Fan C,
Perou CM, Naber S and Kuperwasser C: A novel lung metastasis
signature links Wnt signaling with cancer cell self-renewal and
epithelial-mesenchymal transition in basal-like breast cancer.
Cancer Res. 69:5364–5373. 2009. View Article : Google Scholar : PubMed/NCBI
|
